Dr. Christine Parseghian, MD

• Medical Oncology

• Internal Medicine

*Healthgrades does not verify qualifications for medical specialties. Please verify your provider's specialty and qualifications directly with your provider and applicable medical board.

• University Of Tex Md Anderson Cancer Center

  Fellowship Hospital, 2018

• Ronald Reagan Ucla Medical Center

  Residency Hospital, 2015

• Ronald Reagan Ucla Medical Center

  Internship Hospital, 2013

• Tufts University School Of Medicine

  Medical School, 2012

• Truncal dynamics may trump: serial ctDNA to predict early therapeutic response, 2023-01-17

• Bintrafusp Alfa, an Anti-PD-L1:TGFß Trap Fusion Protein, in Patients with ctDNA-positive, Liver-limited Metastatic Colorectal Cancer, 2022-09-14

• Bintrafusp alfa, an anti-PD-L1:TGF-ß trap fusion protein, in patients with ctDNA-positive, liver-limited metastatic colorectal cancer, 2022-09-14

• Metastatic lung adenocarcinoma mimicking Richter transformation in a patient with chronic lymphocytic leukemia, 2020-09-13

• Mechanisms of Innate and Acquired Resistance to anti-EGFR therapy: A Review of Current Knowledge with a Focus on Rechallenge Therapies, 2019-07-01

• Evaluating for Pseudoprogression in Colorectal and Pancreatic Tumors Treated with Immunotherapy, 2018-03-09

• KRASAmplification in Metastatic Colon Cancer is Associated with a History of Inflammatory Bowel Disease and May Confer Resistance to anti-EGFR Therapy, 2020-05-06